›Inadequate stress dosing
›Recent steroid taper or discontinuation
›Below physiological replacement dose
›Nonadherence to replacement
›Critical medication review
›Glucocorticoid use any route
›Oral, inhaled, topical, intra-articular
›Most common cause of AI overall
›ACTH-suppressing or enzyme-inhibiting drugs
›Opioids suppress ACTH
›Ketoconazole, metyrapone, etomidate, mitotane
›CYP3A4 inducers accelerating cortisol metabolism
›Rifampin and phenytoin
›Carbamazepine and phenobarbital
›Immune checkpoint inhibitors
›Hypophysitis or adrenalitis
›Risk under 1%
›Iatrogenic precipitant caution
›Levothyroxine started in undiagnosed AI
›Increases cortisol clearance
›Can precipitate crisis
Risk factors and collateral
›Personal risk factors
›Prior adrenal crisis as strongest predictor
›Recurrent crisis tendency
›Higher comorbidity burden
›Age over 65 years or adolescence transition
›Care transition gaps
›Reduced reserve
›Family and autoimmune history
›Autoimmune polyendocrine syndromes
›Type 1 diabetes
›Autoimmune thyroid disease
›Other autoimmune associations
›Vitiligo
›Pernicious anemia
›Collateral and adherence
›Medication compliance confirmation
›Nonadherence as common precipitant
›Medical alert identification or steroid card
›Self-injection capability
›Patient ability to self-inject hydrocortisone
›Caregiver availability